Ligand Pharmaceuticals, Inc.
USD0.00
+0.00 (+19.23%)
CEO
Todd C. Davis
IPO Date
2022-11-01
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.00M
| 1,984 |
| $59.61 |
| 25 Sept 2023 | Davis Todd C | director, officer: CHIEF EXECUTIVE OFFICER | P-Purchase | Acquired | 4,000 | $59.38 |
| 10 Jul 2023 | Korenberg Matthew E | PRESIDENT & CHIEF OPERATING | J-Other | Acquired | 376 | $56.78 |
| 21 Jun 2023 | Sabba Stephen L | director | A-Award | Acquired | 1,142 | $0.00 |
| 21 Jun 2023 | Sabba Stephen L | director | A-Award | Disposed | 5,461 | $73.76 |
| 13 Jun 2023 | Davis Todd C | director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | Disposed | 420 | $73.76 |
| 13 Jun 2023 | KOZARICH JOHN W | director | A-Award | Acquired | 1,142 | $0.00 |
| 13 Jun 2023 | KOZARICH JOHN W | director | A-Award | Acquired | 5,461 | $73.76 |
| 13 Jun 2023 | LAMATTINA JOHN L | director | A-Award | Acquired | 1,142 | $0.00 |